PR Newswire | OCTOBER 25, 2016
The Perceptive Credit Opportunities Fund is focused on providing customized debt financing solutions to innovative healthcare companies across all stages and subsectors, including biopharma, medical devices, diagnostics, life science research and healthcare information technology.
Astra Zeneca | DECEMBER 17, 2015
AstraZeneca today announced that it has entered into an agreement to invest in a majority equity stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US.
Forbes | DECEMBER 17, 2015
There have been hundreds of articles written this year about unicorns, those once-mythical startups valued at $1 billion or more by their venture capitalists.